Indivior Pharmaceuticals (INDV) Current Taxes (2021 - 2025)
Historic Current Taxes for Indivior Pharmaceuticals (INDV) over the last 5 years, with Q3 2025 value amounting to $4.0 million.
- Indivior Pharmaceuticals' Current Taxes rose 14444.44% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year increase of 14444.44%. This contributed to the annual value of $7.0 million for FY2024, which is 1250.0% down from last year.
- According to the latest figures from Q3 2025, Indivior Pharmaceuticals' Current Taxes is $4.0 million, which was up 14444.44% from $17.0 million recorded in Q2 2025.
- Indivior Pharmaceuticals' Current Taxes' 5-year high stood at $17.0 million during Q2 2025, with a 5-year trough of -$9.0 million in Q3 2024.
- Moreover, its 5-year median value for Current Taxes was $5.5 million (2021), whereas its average is $2.5 million.
- As far as peak fluctuations go, Indivior Pharmaceuticals' Current Taxes crashed by 8000.0% in 2024, and later surged by 31250.0% in 2025.
- Over the past 5 years, Indivior Pharmaceuticals' Current Taxes (Quarter) stood at $7.0 million in 2021, then increased by 28.57% to $9.0 million in 2022, then dropped by 11.11% to $8.0 million in 2023, then fell by 12.5% to $7.0 million in 2024, then plummeted by 42.86% to $4.0 million in 2025.
- Its last three reported values are $4.0 million in Q3 2025, $17.0 million for Q2 2025, and $12.0 million during Q1 2025.